Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials (Q39291910)

10 September 2017

0 references

Cisplatin and gemcitabine for advanced biliary tract cancer: a meta-analysis of two randomised trials (English)

1 reference

10 September 2017

0 references

1 reference

1 reference

1

1 reference

10 September 2017

J Furuse

2

1 reference

10 September 2017

M Jitlal

3

1 reference

10 September 2017

S Beare

4

1 reference

10 September 2017

N Mizuno

5

1 reference

10 September 2017

H Wasan

6

1 reference

10 September 2017

J Bridgewater

7

1 reference

10 September 2017

T Okusaka

8

1 reference

10 September 2017

publication date

18 December 2013

1 reference

10 September 2017

1 reference

10 September 2017

volume

25

1 reference

10 September 2017

issue

2

1 reference

10 September 2017

page(s)

391-398

1 reference

Epidemiology of biliary tract cancers: an update

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

International comparisons of cumulative risk of gallbladder cancer and other biliary tract cancer, from Cancer Incidence in Five Continents Vol. VIII.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Increase in mortality rates from intrahepatic cholangiocarcinoma in England and Wales 1968-1998.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Increasing incidence and mortality of primary intrahepatic cholangiocarcinoma in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Changing international trends in mortality rates for liver, biliary and pancreatic tumours

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Diagnosis and treatment of cholangiocarcinoma.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Cholangiocarcinoma: thirty-one-year experience with 564 patients at a single institution

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Chemotherapy improves survival and quality of life in advanced pancreatic and biliary cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Best supportive care compared with chemotherapy for unresectable gall bladder cancer: a randomized controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Chemotherapy in advanced biliary tract carcinoma: a pooled analysis of clinical trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Gemcitabine alone or in combination with cisplatin in patients with advanced or metastatic cholangiocarcinomas or other biliary tract tumours: a multicentre randomised phase II study - The UK ABC-01 Study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Cisplatin plus gemcitabine versus gemcitabine for biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Gemcitabine alone or in combination with cisplatin in patients with biliary tract cancer: a comparative multicentre study in Japan

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

Lessons from the comparison of two randomized clinical trials using gemcitabine and cisplatin for advanced biliary tract cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FANNONC%2FMDT540

21 January 2018

Identifiers

DOI

10.1093/ANNONC/MDT540

1 reference

10 September 2017

1 reference